BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

668 related articles for article (PubMed ID: 16950145)

  • 21. PET/CT for the staging and follow-up of patients with malignancies.
    Poeppel TD; Krause BJ; Heusner TA; Boy C; Bockisch A; Antoch G
    Eur J Radiol; 2009 Jun; 70(3):382-92. PubMed ID: 19406595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
    Metser U; Even-Sapir E
    Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Positron emission tomography/computed tomography: the current technology and applications.
    Mittra E; Quon A
    Radiol Clin North Am; 2009 Jan; 47(1):147-60. PubMed ID: 19195540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SPECT/CT imaging: clinical utility of an emerging technology.
    Bybel B; Brunken RC; DiFilippo FP; Neumann DR; Wu G; Cerqueira MD
    Radiographics; 2008; 28(4):1097-113. PubMed ID: 18635631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the joint working group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance.
    Coleman RE; Delbeke D; Guiberteau MJ; Conti PS; Royal HD; Weinreb JC; Siegel BA; Federle MF; Townsend DW; Berland LL; ; ;
    J Nucl Med; 2005 Jul; 46(7):1225-39. PubMed ID: 16000293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [99mTc]sestamibi and [99mTc]tetrofosmin in oncology: SPET and fusion imaging in lung cancer, malignant lymphomas and brain tumors.
    Schillaci O; Spanu A; Madeddu G
    Q J Nucl Med Mol Imaging; 2005 Jun; 49(2):133-44. PubMed ID: 16010251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hybrid imaging technology: from dreams and vision to clinical devices.
    Patton JA; Townsend DW; Hutton BF
    Semin Nucl Med; 2009 Jul; 39(4):247-63. PubMed ID: 19497402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Correlative imaging in cardiology. Principles and clinical application].
    Kuwert T; Römer W; Hornegger J
    Herz; 2007 Mar; 32(2):122-8. PubMed ID: 17401754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PET/CT: panacea, redundancy, or something in between?
    Vogel WV; Oyen WJ; Barentsz JO; Kaanders JH; Corstens FH
    J Nucl Med; 2004 Jan; 45 Suppl 1():15S-24S. PubMed ID: 14736832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 18F-FDG PET/CT delayed images after diuretic for restaging invasive bladder cancer.
    Anjos DA; Etchebehere EC; Ramos CD; Santos AO; Albertotti C; Camargo EE
    J Nucl Med; 2007 May; 48(5):764-70. PubMed ID: 17475965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discrepancies and priorities in staging and restaging malignant lymphoma by SPET, SPET/CT, PET/CT and PET/MRI.
    Chavdarova LI; Tzonevska AD; Piperkova EN
    Hell J Nucl Med; 2013; 16(3):223-9. PubMed ID: 24137584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Applications and software techniques for integrated cardiac multimodality imaging.
    Slomka PJ; Berman DS; Germano G
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):27-41. PubMed ID: 18095905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities.
    Zanzonico P; Dauer L; St Germain J
    Health Phys; 2008 Nov; 95(5):554-70. PubMed ID: 18849690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Scintimammography with a high resolution dedicated breast camera in comparison with SPECT/CT in primary breast cancer detection.
    Spanu A; Chessa F; Sanna D; Cottu P; Manca A; Nuvoli S; Madeddu G
    Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):271-80. PubMed ID: 18596669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SPECT/CT in oncology: the fusion of two imaging modalities is a new standard of care.
    Tagliabue L; Schillaci O
    Q J Nucl Med Mol Imaging; 2007 Dec; 51(4):285-9. PubMed ID: 17923823
    [No Abstract]   [Full Text] [Related]  

  • 36. PET and PET/CT in pediatric oncology.
    Jadvar H; Connolly LP; Fahey FH; Shulkin BL
    Semin Nucl Med; 2007 Sep; 37(5):316-31. PubMed ID: 17707239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Directions and magnitudes of misregistration of CT attenuation-corrected myocardial perfusion studies: incidence, impact on image quality, and guidance for reregistration.
    Kennedy JA; Israel O; Frenkel A
    J Nucl Med; 2009 Sep; 50(9):1471-8. PubMed ID: 19690038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imaging to optimally stage lung cancer: conventional modalities and PET/CT.
    Truong MT; Munden RF; Movsas B
    J Am Coll Radiol; 2004 Dec; 1(12):957-64. PubMed ID: 17411738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Localization of metastases from malignant pheochromocytoma in patients undergoing 131I-MIBG therapy with manually fused 123I-MIBG SPECT and CT images.
    Kizu H; Takayama T; Tsushima H; Noguchi A; Nakajima K; Onoguchi M; Kinuya S
    J Nucl Med Technol; 2008 Dec; 36(4):186-8. PubMed ID: 19008288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Objective and subjective comparison of standard 2-D and fully 3-D reconstructed data on a PET/CT system.
    Strobel K; Rüdy M; Treyer V; Veit-Haibach P; Burger C; Hany TF
    Nucl Med Commun; 2007 Jul; 28(7):555-9. PubMed ID: 17538397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.